31 filings
8-K
VVUS
Vivus Inc
31 Dec 19
Entry into a Material Definitive Agreement
7:36am
8-K
VVUS
Vivus Inc
18 Dec 19
VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Adolescents with Obesity
7:35am
8-K
VVUS
Vivus Inc
20 Nov 19
Other Events
7:35am
8-K
VVUS
Vivus Inc
8 Nov 19
VIVUS, Inc. Q3 2019 Earnings Conference Call
4:11pm
8-K
VVUS
Vivus Inc
5 Nov 19
VIVUS Reports Third Quarter 2019 Financial Results
4:10pm
8-K
p4121ll9ixl
28 Oct 19
VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
7:35am
8-K
wgam1rg oawt6czyuts
21 Oct 19
VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit
7:35am
8-K
t167z
7 Oct 19
VIVUS Announces Acceptance of Qsymia Decentralized Marketing Authorization Application in Europe
7:35am
8-K
7cffy3u4z el
3 Oct 19
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
7:36am
8-K
d7dlul94w5qy90rf
5 Sep 19
Regulation FD Disclosure
7:31am
8-K
ev0viyjwyy
27 Aug 19
Other Events
7:36am
8-K
r6og54f hb5fhs18e
20 Aug 19
Other Events
7:35am
8-K
u2n 9ym1acohzyc
9 Aug 19
VIVUS, Inc. Q2 2019 Earnings Conference Call
4:05pm
8-K
vqu77u 5v
6 Aug 19
VIVUS Reports Second Quarter 2019 Financial Results
4:10pm
8-K
zgy2xa4qpmy 07g1g
5 Aug 19
VIVUS Announces Approval of Qsymia® in the Republic of Korea
7:35am
8-K
tbqjkp7gayu jt
26 Jun 19
Entry into a Material Definitive Agreement
4:11pm
8-K
398nh3pnphkxokl
11 Jun 19
Other Events
7:32am
8-K
uz9zq0ecl d2y
7 Jun 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
nthcuubz5lqxz tzfra
28 May 19
Entry into a Material Definitive Agreement
4:06pm
8-K
ss0avcn8ki2e21qxgsu
28 May 19
Other Events
7:35am